chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 66.0
Sex: M
Vaccine: FLU3, PPV
Symptoms: Injection site swelling, Injection site warmth
Clinical narrative: Patient reported redness, heat, and swelling from left shoulder to elbow. Also has joint pain in elbows and knees that has now somewhat subsided. Redness started about 6 hours after the injections and is still visible. Patient stated he was very fatigued the day after immunization and was bed ridden that day, slept from mid afternoon until the next morning. Recommended that patient see his primary physician if no improvement or symptoms worsen. Patient has previously recieved influenza vaccine with no reaction, spouse reports that he had some adverse reaction to PREVNAR 13 given in 2017, patient does not remember any adverse reaction.
Age: 12.0
Sex: M
Vaccine: TDAP
Symptoms: Syncope, Vomiting
Clinical narrative: After RN administered tdap vaccination client fainted. Client had been sitting on examination table and was laid down. RN obtained pulse oximeter and placed it on clients finger, but pulse oximeter was not functioning. RN called for secretary who contacted director who came in to examination room. Client came to and began vomiting. Client was sat up and provided with garbage can. Cool paper towels were placed on clients forehead and neck and client was provided with orange juice which he took sips of. Client was AAOx3 after incident. Client remained sitting on exam table, sipping orange juice with cool towels for approximately 10 minutes. Client was then assisted in to sitting, and then standing position and stated that he felt "fine". Client and MOC deny questions or concerns, client was walked out to waiting room and left the facility with his mother at approximately 0930.
Age: 58.0
Sex: M
Vaccine: VARZOS
Symptoms: Pain in extremity, Product preparation error
Clinical narrative: The patient was given the Adjuvant Suspension component of the vaccine without reconstituting with the Lyophilized Antigen before the injection. This was caught with looking at inventory 4 days later and we informed the patient. He reported localized left arm pain but no other problems.
Age: 66.0
Sex: F
Vaccine: PNC13
Symptoms: Erythema, Injection site reaction, Skin exfoliation, Skin warm, Vaccination site mass
Clinical narrative: Pt came to the pharmacy a few days after the administration of the vaccine with the concern that she had painful and swelling right arm when the vaccine was administered. The pharmacist on duty examined her right arm. It was red and warm on touch. Pt was advised to take TYLENOL (acetaminophen) 500 mg tablets three times a day as needed and also to apply cold compress on her arm. A week later, pt came to the pharmacy and the pharmacist examined again. Her right arm is no longer swelling nor red and the pain subsided, but pt had concern that there was a small bump inside her right arm where the vaccine was administered. There was also some scaling skin on certain area of her right arm when vaccine was administered. Pt was advised to apply a moisturizing cream (EUCERIN or CERAVE) two to three times a day on that skin area. A few days later on 08/10, pt came to the pharmacy again. The pharmacist examined her right arm, the scaling skin improved but the small bump inside the right arm could still be filled. Pt wanted to file VAERS report. Pharmacist already explained to her what VAERS and what did it mean to her.
Age: 66.0
Sex: F
Vaccine: PNC13
Symptoms: Vaccination site pain, Vaccination site swelling
Clinical narrative: Pt came to the pharmacy a few days after the administration of the vaccine with the concern that she had painful and swelling right arm when the vaccine was administered. The pharmacist on duty examined her right arm. It was red and warm on touch. Pt was advised to take TYLENOL (acetaminophen) 500 mg tablets three times a day as needed and also to apply cold compress on her arm. A week later, pt came to the pharmacy and the pharmacist examined again. Her right arm is no longer swelling nor red and the pain subsided, but pt had concern that there was a small bump inside her right arm where the vaccine was administered. There was also some scaling skin on certain area of her right arm when vaccine was administered. Pt was advised to apply a moisturizing cream (EUCERIN or CERAVE) two to three times a day on that skin area. A few days later on 08/10, pt came to the pharmacy again. The pharmacist examined her right arm, the scaling skin improved but the small bump inside the right arm could still be filled. Pt wanted to file VAERS report. Pharmacist already explained to her what VAERS and what did it mean to her.
Age: 5.0
Sex: F
Vaccine: DTAPIPV
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: Red and swollen over shot site.
Age: 20.0
Sex: M
Vaccine: MENB
Symptoms: Urticaria
Clinical narrative: Vaccine given 8/9/18. Morning of 8/13/18 with urticaria of elbows, proximal dorsal forearms and distal thighs (above knees). There were no obvious precipitating events for the urticaria.
Age: 4.0
Sex: F
Vaccine: DTAPIPV, MMRV
Symptoms: Rash, Urticaria
Clinical narrative: Per parents a rash started to break out on 08/10/2018 and the parents called the on-call doctor for the Health Department. Since the doctor could not physically see child, doctor sent to the parents/client to the nearest hospital ER. At the hospital, the client was prescribed Steroids and Benadryl. Today, the client was seen in the health center (08/13/2018), what appears to be hives per photos from parents, the client is recovering from the hives and no current hives seen on body. Last dose of Benadryl was given to client at 8:00pm on 08/13/2018.
Age: 63.0
Sex: F
Vaccine: VARZOS
Symptoms: Abdominal discomfort, Bone pain, Dizziness, Headache, Pain
Clinical narrative: About one hour after her 2nd dose of SHRINGRIX she experienced headache, dizziness, wooziness and upset stomach. With a few hours she began to have all over body aches which then became worse and described as bone aches as well in hips, back and neck. By the following evening symptoms were subsiding, but she still has reoccurring headaches which she never had before.
Age: 4.0
Sex: M
Vaccine: DTAPIPV, MMRV, DTAPIPV, MMRV
Symptoms: Dyspnoea, Eye swelling, Full blood count, White blood cell count increased
Clinical narrative: Swollen eyes, difficulty breathing. Given 0.2mg epinephrine, 25mg BENADRYL and 50mg SOLUMEDROL with resolution of swollen eyes and improved breathing.
Age: 4.0
Sex: M
Vaccine: DTAPIPV, MMRV, DTAPIPV, MMRV
Symptoms: Dyspnoea, Erythema, Eye swelling
Clinical narrative: Swollen eyes, difficulty breathing. Given 0.2mg epinephrine, 25mg BENADRYL and 50mg SOLUMEDROL with resolution of swollen eyes and improved breathing.
Age: 4.0
Sex: M
Vaccine: DTAPIPV, MMRV
Symptoms: Ataxia, CSF test normal, CSF virus no organisms observed, Dehydration, Encephalitis
Clinical narrative: Patient develop severe cerebelitis with ataxia and dehydration requiring admnission in the Hospital for several days.
Age: 4.0
Sex: M
Vaccine: DTAPIPV, MMRV
Symptoms: Immunology test normal, Nuclear magnetic resonance imaging brain abnormal, Viral test negative
Clinical narrative: Patient develop severe cerebelitis with ataxia and dehydration requiring admnission in the Hospital for several days.
Age: 69.0
Sex: F
Vaccine: PNC13
Symptoms: Injection site erythema, Injection site reaction, Injection site warmth
Clinical narrative: Redness, warm, tough area at injection. Pt seen by MD.
Age: 0.5
Sex: F
Vaccine: DTAPHEPBIP, HIBV, PNC13, RV5
Symptoms: Alanine aminotransferase increased, Anaemia, Aspartate aminotransferase increased, Blood bilirubin increased, C-reactive protein increased
Clinical narrative: Admitted for fever, cough, decreased intake, and jaundice. Initially thought to have UTI due to positive urine culture at facility but further symptoms of Kawasaki's disease presented after admission: conjunctivitis with limbic sparing, continued fevers, transaminitis, truncal rash, elevated inflammatory markers, anemia, and thrombocytosis. Patient was treated with IVIG and high-dose aspirin prior to discharge. Echo revealed mild ectasia of coronary arteries. Upon re-examination outpatient 1 week after discharge, continued Kawasaki's physical symptoms were noted and aspirin was continued.
Age: 0.5
Sex: F
Vaccine: DTAPHEPBIP, HIBV, PNC13, RV5
Symptoms: Conjunctivitis, Coronary artery dilatation, Cough, Culture urine positive, Echocardiogram abnormal
Clinical narrative: Admitted for fever, cough, decreased intake, and jaundice. Initially thought to have UTI due to positive urine culture at facility but further symptoms of Kawasaki's disease presented after admission: conjunctivitis with limbic sparing, continued fevers, transaminitis, truncal rash, elevated inflammatory markers, anemia, and thrombocytosis. Patient was treated with IVIG and high-dose aspirin prior to discharge. Echo revealed mild ectasia of coronary arteries. Upon re-examination outpatient 1 week after discharge, continued Kawasaki's physical symptoms were noted and aspirin was continued.
Age: 0.5
Sex: F
Vaccine: DTAPHEPBIP, HIBV, PNC13, RV5
Symptoms: Hypophagia, Immunoglobulin therapy, Inflammatory marker increased, Jaundice, Kawasaki's disease
Clinical narrative: Admitted for fever, cough, decreased intake, and jaundice. Initially thought to have UTI due to positive urine culture at facility but further symptoms of Kawasaki's disease presented after admission: conjunctivitis with limbic sparing, continued fevers, transaminitis, truncal rash, elevated inflammatory markers, anemia, and thrombocytosis. Patient was treated with IVIG and high-dose aspirin prior to discharge. Echo revealed mild ectasia of coronary arteries. Upon re-examination outpatient 1 week after discharge, continued Kawasaki's physical symptoms were noted and aspirin was continued.
Age: 0.5
Sex: F
Vaccine: DTAPHEPBIP, HIBV, PNC13, RV5
Symptoms: Pyrexia, Rash, Red blood cell sedimentation rate increased, Thrombocytosis, Transaminases increased
Clinical narrative: Admitted for fever, cough, decreased intake, and jaundice. Initially thought to have UTI due to positive urine culture at facility but further symptoms of Kawasaki's disease presented after admission: conjunctivitis with limbic sparing, continued fevers, transaminitis, truncal rash, elevated inflammatory markers, anemia, and thrombocytosis. Patient was treated with IVIG and high-dose aspirin prior to discharge. Echo revealed mild ectasia of coronary arteries. Upon re-examination outpatient 1 week after discharge, continued Kawasaki's physical symptoms were noted and aspirin was continued.
Age: 0.5
Sex: F
Vaccine: DTAPHEPBIP, HIBV, PNC13, RV5
Symptoms: Urinary tract infection
Clinical narrative: Admitted for fever, cough, decreased intake, and jaundice. Initially thought to have UTI due to positive urine culture at facility but further symptoms of Kawasaki's disease presented after admission: conjunctivitis with limbic sparing, continued fevers, transaminitis, truncal rash, elevated inflammatory markers, anemia, and thrombocytosis. Patient was treated with IVIG and high-dose aspirin prior to discharge. Echo revealed mild ectasia of coronary arteries. Upon re-examination outpatient 1 week after discharge, continued Kawasaki's physical symptoms were noted and aspirin was continued.
Age: 84.0
Sex: M
Vaccine: TDAP, VARZOS
Symptoms: Immediate post-injection reaction, Injected limb mobility decreased, Injection site pain
Clinical narrative: Pt had immediate pain on injection of the SHINGRIX vaccine, pain did not go away and by the next morning was so severe he could not move his arm.
Sex: U
Vaccine: MMR
Symptoms: Expired product administered, No adverse event
Clinical narrative: This spontaneous report was received from a Registered Nurse and refers to a patient of an unknown age and gender. The patient's concurrent conditions, medical history, historical drugs and concomitant therapies were not reported. On an unspecified date in 2016, the patient was inadvertently vaccinated an expired dose of M-M-R II (dose, route, lot number and expiration date were not reported) for prophylaxis. On 09-AUG-2018, the patient returned to be vaccinated with another dose of M-M-R II (dose, route, lot number and expiration date were not reported) for prophylaxis. No adverse effects reported. This is one of two reports received from the same source. Sender's Comments: US-009507513-1808USA004943.
Sex: U
Vaccine: HPV9
Symptoms: No adverse event, Product storage error
Clinical narrative: This spontaneous report as received from a other health professional refers to a patient of unknown age. On an unknown date the patient was vaccinated with GARDASIL 9 (lot # N025429) for prophylaxis. On an unknown date the patient experienced product storage error and no adverse event. The outcome of product storage error and no adverse event is unknown. The reporter considered product storage error and no adverse event to be not assessed to GARDASIL 9.
Age: 63.0
Sex: M
Vaccine: VARZOS
Symptoms: Injection site pain
Clinical narrative: This case was reported by a pharmacist via call center representative and described the occurrence of injection site pain in a 63-year-old male patient who received SHINGRIX (batch number M224F ?, expiry date 8th February 2021) for prophylaxis. On 31st July 2018 11:30, the patient received SHINGRIX. On an unknown date, less than a week after receiving SHINGRIX, the patient experienced injection site pain. On an unknown date, the outcome of the injection site pain was not recovered/not resolved. It was unknown if the reporter considered the injection site pain to be related to SHINGRIX. Additional details were provided as follows: This reporter stated that the patient wife came to the pharmacy and just happened to mention that her husband had been experienced side effect from the vaccine. The patient's wife said that over the past few days, he had soreness and pain at and around the injection site. The pain was coming from being painful to the touch. The patient's wife told the pharmacist that the area was about the size of a tennis ball. The side effects had not resolved.
Age: 18.0
Sex: M
Vaccine: HEPA, MENB, MNQ
Symptoms: Injection site erythema, Injection site nodule, Injection site swelling, Injection site warmth
Clinical narrative: This case was reported by a consumer via call center representative and described the occurrence of injection site swelling in a 18-year-old male patient who received BEXSERO for prophylaxis. Concomitant products included Hepatitis A vaccine and MENVEO. On 16th May 2018, the patient received the 1st dose of BEXSERO. On 16th May 2018, less than a day after receiving BEXSERO, the patient experienced injection site swelling, injection site warmth, injection site erythema and injection site nodule. On an unknown date, the outcome of the injection site swelling, injection site warmth, injection site erythema and injection site nodule were recovered/resolved. It was unknown if the reporter considered the injection site swelling, injection site warmth, injection site erythema and injection site nodule to be related to BEXSERO. Additional details reported as follows: The reporter was the mother. It was unknown on which arm BEXSERO was administered as the patient received 2 other vaccines (Hep A and MCv4) on the same day along with BEXSERO. There was redness and swelling in the form of a nodule at the injection site that lasted for 10 days. In May 2018, the events lasted for 10 days. The patient had denied permission to contact their physician. For tolerance after 2nd dose refer case US2018GSK146072.
Age: 75.0
Sex: F
Vaccine: VARZOS
Symptoms: Condition aggravated, Injection site erythema
Clinical narrative: This case was reported by a nurse via call center representative and described the occurrence of bursitis worsened in a 75-year-old female patient who received SHINGRIX for prophylaxis. Concurrent medical conditions included bursitis (in her right arm or shoulder started on Saturday, 28th July 2018) and pain (bursitis pain started on 28th July 2018). On 30th July 2018, the patient received SHINGRIX (intramuscular). In July 2018, less than a week after receiving SHINGRIX, the patient experienced bursitis worsened and injection site erythema. On an unknown date, the outcome of the bursitis worsened was not recovered/not resolved and the outcome of the injection site erythema was recovered/resolved. The reporter considered the bursitis worsened to be unrelated to SHINGRIX. It was unknown if the reporter considered the injection site erythema to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The patient received SHINGRIX vaccine in the left arm. The bursitis pain had gotten worse over the week but the healthcare professional (HCP) did not believe it was related to SHINGRIX. This was how it presented the last time the patient experienced bursitis. The patient did develop redness around the injection site on left arm the day after receiving SHINGRIX but this had since resolved. The HCP called to see if steroids could be administered after SHINGRIX for the bursitis.
Age: 65.0
Sex: F
Vaccine: VARZOS
Symptoms: Incorrect route of drug administration, Injection site erythema, Injection site warmth
Clinical narrative: This case was reported by a pharmacist via call center representative and described the occurrence of injection site warmth in a 65-year-old female patient who received SHINGRIX (batch number G933B ? (GSK note: the reported lot number did not match with any GSK lot number), expiry date 22nd November 2020) for prophylaxis. On 1st August 2018, the patient received the 1st dose of SHINGRIX (subcutaneous) .5 ml. On 1st August 2018, unknown after receiving SHINGRIX, the patient experienced intramuscular formulation administered by other route. In August 2018, the patient experienced injection site warmth and injection site erythema. On an unknown date, the outcome of the injection site warmth, injection site erythema and intramuscular formulation administered by other route were unknown. It was unknown if the reporter considered the injection site warmth and injection site erythema to be related to SHINGRIX. Additional details were provided as follows: The patient received SHINGRIX vaccine on the right arm. The pharmacist stated that the patient came on the date of reporting and showed the area of the injection site was red and warm. When pharmacist checked the injection site, it looked like the vaccine was administered subcutaneously at a 45 degree angle instead of intramuscularly. This led to incorrect route of vaccine administration. No further details were provided.
Sex: F
Vaccine: MENB
Symptoms: Hypoaesthesia, Injection site erythema, Injection site induration, Pain in extremity, Rash macular
Clinical narrative: This case was reported by a physician via call center representative and described the occurrence of injection site induration in a 16-year-old female patient who received BEXSERO for prophylaxis. On an unknown date, the patient received the 1st dose of BEXSERO. On an unknown date, less than a month after receiving BEXSERO, the patient experienced injection site induration, numbness of upper extremities, pain in arm and erythromacular rash. On an unknown date, the outcome of the injection site induration and erythromacular rash were unknown and the outcome of the numbness of upper extremities and pain in arm were recovered/resolved. It was unknown if the reporter considered the injection site induration, numbness of upper extremities, pain in arm and erythromacular rash to be related to BEXSERO. Additional details were provided as follows: The age at vaccination was not reported, but it could be 15 or 16 years old. The patient received BEXSERO vaccine on an unknown arm. The physician reported that the patient reported induration at the site, pain to her arm for 2 weeks, numbness to the arm which faded and few red spots around the injection site.
Age: 65.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site pruritus
Clinical narrative: This case was reported by a pharmacist via call center representative and described the occurrence of injection site itching in a 65-year-old female patient who received SHINGRIX (batch number HG4P3, expiry date 13th July 2020) for prophylaxis. Concomitant products included Sumatriptan, butalbital and LEXAPRO. On 14th May 2018, the patient received the 1st dose of SHINGRIX (intramuscular) .5 ml. On 16th May 2018, 2 days after receiving SHINGRIX, the patient experienced injection site itching. On 16th June 2018, the outcome of the injection site itching was recovered/resolved. It was unknown if the reporter considered the injection site itching to be related to SHINGRIX. Additional details were provided as follows: The patient received SHINGRIX in the right deltoid. The patient reported to the pharmacist that she followed up with her physician.
Age: 63.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site pruritus, Injection site rash
Clinical narrative: This case was reported by a other health professional via call center representative and described the occurrence of injection site rash in a 63-year-old female patient who received SHINGRIX (batch number 5NY3B, expiry date 13th July 2020) for prophylaxis. On 5th June 2018, the patient received the 1st dose of SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced injection site rash, injection site erythema and injection site itching. On an unknown date, the outcome of the injection site rash, injection site erythema and injection site itching were recovered/resolved. It was unknown if the reporter considered the injection site rash, injection site erythema and injection site itching to be related to SHINGRIX. Additional details were provided as follows: After receiving SHINGRIX, the patient experienced light reddish rash and itching at injection site which lasted for 1 week.
Age: 87.0
Sex: M
Vaccine: FLU4, VARZOS
Symptoms: Injection site pain
Clinical narrative: This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a 87-year-old male patient who received SHINGRIX for prophylaxis. Concomitant products included Influenza vaccine Quadrivalent unspecified season. On 7th August 2018 11:02, the patient received the 1st dose of SHINGRIX (intramuscular). On 7th August 2018, less than a day after receiving SHINGRIX, the patient experienced injection site pain. On an unknown date, the outcome of the injection site pain was unchanged. It was unknown if the reporter considered the injection site pain to be related to SHINGRIX. Additional details were provided as follows: On 7th August 2018, the patient received flu shot on the left arm as concomitant vaccine. The patient received SHINGRIX vaccine on right arm. The patient stated that at the site of injection and the area below the arm where he received SHINGRIX vaccine was sore and painful. The patient had denied permission to contact their physician. No further details were provided. The patient would follow up with his healthcare provider.
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site mass, Injection site pain, Injection site swelling, Injection site warmth
Clinical narrative: This case was reported by a other health professional via sales rep and described the occurrence of injection site lump in a adult female patient who received SHINGRIX (batch number 7X3EJ, expiry date 13th October 2020) for prophylaxis. On an unknown date, the patient received SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced injection site lump, injection site pain, injection site warmth, injection site erythema and injection site swelling. On an unknown date, the outcome of the injection site lump, injection site pain, injection site warmth, injection site erythema and injection site swelling were unknown. It was unknown if the reporter considered the injection site lump, injection site pain, injection site warmth, injection site erythema and injection site swelling to be related to SHINGRIX. Additional details were provided as follows: This case was reported by a Clinical Coordinator. The age at vaccination was not reported. The patient had severe adverse reaction which was described as an egg-sized lump and extreme pain, the area was hot, red and swollen.
Sex: M
Vaccine: VARZOS
Symptoms: Fatigue, Herpes zoster, Lymph node pain, Myalgia, Paraesthesia
Clinical narrative: This case was reported by a consumer via call center representative and described the occurrence of shingles in a male patient who received SHINGRIX for prophylaxis. On 6th July 2018, the patient received the 1st dose of SHINGRIX. On 15th July 2018, 9 days after receiving SHINGRIX, the patient experienced shingles. In July 2018, the patient experienced muscle pain, lymph node pain, tingling skin and fatigue. On an unknown date, the outcome of the shingles, muscle pain, lymph node pain, tingling skin and fatigue were unknown. It was unknown if the reporter considered the shingles, muscle pain, lymph node pain, tingling skin and fatigue to be related to SHINGRIX. Additional information was received as follows: The age at vaccination was not reported. In the week followed by the vaccination, the patient experienced muscle pain, sore lymph glands, tingling skin and fatigue. The patient developed a full-blown case of shingles which was diagnosed by 2 different physicians. The patient questioned if he should risk getting the 2nd shot.
Sex: F
Vaccine: FLU4
Symptoms: Chills, Malaise, Pyrexia, Vomiting
Clinical narrative: This case was reported by a consumer via call center representative and described the occurrence of sickness in a elderly female patient who received Influenza vaccine Quadrivalent for an unknown indication. On an unknown date, the patient received Influenza vaccine Quadrivalent. On an unknown date, unknown after receiving Influenza vaccine Quadrivalent, the patient experienced sickness, fever, chills and vomiting. On an unknown date, the outcome of the sickness, fever, chills and vomiting were recovered/resolved. It was unknown if the reporter considered the sickness, fever, chills and vomiting to be related to Influenza vaccine Quadrivalent. Additional details were provided as follows: The age at the vaccination was not reported. The patient received an unknown flu vaccine three years ago that caused her to be deathly sick with a fever, chills and vomiting. This case was linked to the case US2018140244, reported by the same reporter for the same patient.
Age: 53.0
Sex: F
Vaccine: VARZOS
Symptoms: Influenza like illness, Injection site erythema, Injection site swelling
Clinical narrative: Pt called her pharmacy 8/12/18 to inform us she was experiencing flu like symptoms starting the day after the SHINGRIX vaccination. Pt also complains of swelling and redness in the left arm (injection site reaction).
Age: 73.0
Sex: M
Vaccine: VARZOS
Symptoms: Erythema, Peripheral swelling, Skin warm
Clinical narrative: Patient developed large red swollen area on upper arm, warm to the touch. Reported no itching or burning.
Age: 4.0
Sex: M
Vaccine: UNK
Symptoms: Varicella
Clinical narrative: Child Dx with Varicella at todays visit.
Age: 36.0
Sex: M
Vaccine: RAB
Symptoms: Chills, Dizziness, Headache, Nausea, Pyrexia
Clinical narrative: Chills, Fever, Headache, Nausea, Vomiting, Dizziness. 2 hours after injection symptoms started, Lastly 12-16 hours, Patient did not report adverse reaction until today (8/13/18), before he received his third injection of the series. Patient did not receive any treatment or self-treat symptoms for adverse reaction.
Age: 36.0
Sex: M
Vaccine: RAB
Symptoms: Vomiting
Clinical narrative: Chills, Fever, Headache, Nausea, Vomiting, Dizziness. 2 hours after injection symptoms started, Lastly 12-16 hours, Patient did not report adverse reaction until today (8/13/18), before he received his third injection of the series. Patient did not receive any treatment or self-treat symptoms for adverse reaction.
Age: 20.0
Sex: F
Vaccine: HEP
Symptoms: Pruritus, Rash
Clinical narrative: Pt called stating rash was occurring on lower extremities. Pt informed to take BENADRYL to decrease itching and go to urgent care or emergency room if needed.
Age: 54.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site pain, Injection site swelling, Pain, Pain in extremity
Clinical narrative: Pt had red swelling of right arm at site of injection, a diameter of 2-3 inches. Pt states pain was radiating through her entire right arm. Pain was most severe the day after immunization and the following day the pain has subsided. Currently the pain is only at the injection site. Report body ache and low grade fever on 8/12. No reported body ache or fever on 8/13/18.
Age: 54.0
Sex: F
Vaccine: VARZOS
Symptoms: Pyrexia
Clinical narrative: Pt had red swelling of right arm at site of injection, a diameter of 2-3 inches. Pt states pain was radiating through her entire right arm. Pain was most severe the day after immunization and the following day the pain has subsided. Currently the pain is only at the injection site. Report body ache and low grade fever on 8/12. No reported body ache or fever on 8/13/18.
Age: 84.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Urticaria
Clinical narrative: Patient presented today with "hives" along her left arm, her back, as well as on her chest/breast area and her left underarm. Patient saw her primary physician and received RX for antiviral and pain rx. (Filled elsewhere, so no other info available.) MD told patient to return to Immunization site to assure her reaction was reported.
Age: 84.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Axillary pain, Back pain, Pain in extremity, Urticaria
Clinical narrative: Patient presented today with "hives" along her left arm, her back, as well as on her chest/breast area and her left underarm. Patient saw her primary physician and received RX for antiviral and pain rx. (Filled elsewhere, so no other info available.) MD told patient to return to Immunization site to assure her reaction was reported.
Age: 62.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site pain, Injection site paraesthesia, Injection site swelling
Clinical narrative: Per pt the skin near the injection site was swollen and she felt tingling pain sensation. The adverse reaction is localized and pt has taken TYLENOL to help with pain. Instructed pt to use cold compression to help with the swollen and follow up with family doctor if no improvement.
Age: 67.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Rash
Clinical narrative: Idiopathic rash on bottom, developed within 2 days of vaccine administration.
Age: 67.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Herpes simplex
Clinical narrative: Idiopathic rash on bottom, developed within 2 days of vaccine administration.
Age: 84.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site inflammation, Pruritus, Skin warm
Clinical narrative: INFLAMED RED AREA APPROX SIZE OF A BASEBALL DIRECTLY WHERE INJECTION WOULD HAVE BEEN GIVEN- LEFT UPPER DELTOID. WARM/HOT TO THE TOUCH. PT ALSO COMPLAINED OF ITCHING. NO FEVER. ADVISED PT TO TRY SOME ZYRTEC OVER THE COUNTER BUT ALSO WAS ADVISED HER TO CONTACT HER DR AND LET THEM KNOW WHAT SHE WAS EXPERIENCING. PT STATED SHE WAS LIKELY GOING TO GO STOP BY OFFICE TODAY AS IT WAS CLOSEBY. I CALLED OFFICE AROUND 4PM AND SPOKE WITH EMPLOYEE AND INFORMED THEM OF THE SITUATION. SHE SAID THEY WOULD FOLLOW UP WITH PT.
Age: 4.0
Sex: F
Vaccine: DTAP, IPV, MMR, VARCEL
Symptoms: Injection site rash, Injection site swelling, Injection site warmth
Clinical narrative: Swelling, warmth and rash at immunization site.
Age: 62.0
Sex: F
Vaccine: VARZOS
Symptoms: Hypersensitivity, Pain, Pruritus, Rash
Clinical narrative: Allergic reaction Exposures: SHINGRIX 8/11/18 Rash: left shoulder onset day after injection. Itching: mild Pain: mild Throat swelling / difficulty breathing: no Wheezing: no Facial swelling: no Pain: mild Fever: no Mucous membrane involvement: no.
Age: 12.0
Sex: F
Vaccine: TDAP, TDAP
Symptoms: Blood glucose normal, Dyskinesia, Feeling abnormal, Seizure, Syncope
Clinical narrative: Patient received ADACEL vaccine at the pharmacy and felt okay after the vaccine. Approximately 10-15 minutes after receiving vaccine, patient returned to pharmacy and said that she felt weird and had a ringing in her ears. She was sitting on the pharmacy bench when she fainted and then had convulsions/involuntary body movements for approximately 5-10 seconds. Paramedics were called and arrived within approximately 5 minutes.
Age: 12.0
Sex: F
Vaccine: TDAP, TDAP
Symptoms: Tinnitus
Clinical narrative: Patient received ADACEL vaccine at the pharmacy and felt okay after the vaccine. Approximately 10-15 minutes after receiving vaccine, patient returned to pharmacy and said that she felt weird and had a ringing in her ears. She was sitting on the pharmacy bench when she fainted and then had convulsions/involuntary body movements for approximately 5-10 seconds. Paramedics were called and arrived within approximately 5 minutes.
Age: 12.0
Sex: F
Vaccine: TDAP, TDAP
Symptoms: Blood glucose normal, Confusional state, Dyskinesia, Eye movement disorder, Hypoacusis
Clinical narrative: Patient received ADACEL vaccine at the pharmacy and felt okay after the vaccine. Approximately 10-15 minutes after receiving vaccine, patient returned to pharmacy and said that she felt weird and had a ringing in her ears. She was sitting on the pharmacy bench when she fainted and then had convulsions/involuntary body movements for approximately 5-10 seconds. Paramedics were called and arrived within approximately 5 minutes.
Age: 12.0
Sex: F
Vaccine: TDAP, TDAP
Symptoms: Pallor, Tinnitus
Clinical narrative: Patient received ADACEL vaccine at the pharmacy and felt okay after the vaccine. Approximately 10-15 minutes after receiving vaccine, patient returned to pharmacy and said that she felt weird and had a ringing in her ears. She was sitting on the pharmacy bench when she fainted and then had convulsions/involuntary body movements for approximately 5-10 seconds. Paramedics were called and arrived within approximately 5 minutes.
Age: 65.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema
Clinical narrative: Large red area around vaccine site, advised Benadryl, otc pain reliever and cool compress.
Age: 64.0
Sex: F
Vaccine: VARZOS
Symptoms: Erythema, Headache, Insomnia, Musculoskeletal stiffness, Nausea
Clinical narrative: Sore stif arm 8:15. Headache early afternoon nausea- couldn't sleep because my arm hurt so much Took Advil every 8 hours. Day 2 continued symptoms so continued the Advil. Sunday pm my arm was hot and red. About a 2.5 inch area of the shot. Day 3 red area itches, hot  but not as tender. Much less nausea.
Age: 64.0
Sex: F
Vaccine: VARZOS
Symptoms: Pain in extremity, Pruritus, Skin warm, Tenderness
Clinical narrative: Sore stif arm 8:15. Headache early afternoon nausea- couldn't sleep because my arm hurt so much Took Advil every 8 hours. Day 2 continued symptoms so continued the Advil. Sunday pm my arm was hot and red. About a 2.5 inch area of the shot. Day 3 red area itches, hot  but not as tender. Much less nausea.
Age: 50.0
Sex: F
Vaccine: DT, FLU4, PPV
Symptoms: Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: On 8/13/2018 I received a phone call from the pt who stated she received 3 vaccines on 8/11 and she is experiencing pain on the injection site, redness and swelling at the affected area. I recommended cold compresses for inflammation, ibuprofen for pain, and diphenhydramine for itch. I asked the pt to call me back if symptoms persist. Also to call MD if symptoms do not go away. Pt did not call me back. I called her at 8 pm. She was not available. I left a message to call me back. She did not call back before closing.
Age: 82.0
Sex: M
Vaccine: VARZOS
Symptoms: Chills, Dyspnoea, Fatigue, Influenza like illness, Pyrexia
Clinical narrative: Patient reported uncontrollable shivers that started in the middle of the night. Which then gave him trouble breathing. He believes because of his lung condition he got tired from the shivering and had trouble breathing. Then the following day had Flu like symptoms fever. But the next day all symptoms were gone. Reported to me on 08/13/18.
Age: 54.0
Sex: M
Vaccine: VARZOS
Symptoms: Incorrect route of drug administration, Injection site reaction, Rash erythematous
Clinical narrative: When patient came for the second dose of SHINGRIX, he showed me a photo he had taken of his arm with a red rash in the inner part of his left arm where you would have given the ZOSTAVAX vaccine subcutaneously. Patient did state that the vaccine was given there. I explained that it should have been given in the deltoid area. The area has cleared up since then. His main concern is that the vaccine would be as effective since it wasn't given correctly. I told him I would contact the manufacturer and follow up with him on it.
Age: 61.0
Sex: F
Vaccine: VARZOS
Symptoms: Ear discomfort, Erythema, Fatigue, Headache, Injection site rash
Clinical narrative: I had a stuffy nose. Rash at the injection site. Headache. Ear ringing. Ear pressure. Body aches. Extreme fatigue. Developed two small circular areas (2-4mm)  3 days post vaccination on my right forearm and left upper arm with a reddened circle with a white center, mild itching also noted. These areas disappeared when cleaned and antibacterial ointment applied overnight.
Age: 61.0
Sex: F
Vaccine: VARZOS
Symptoms: Nasal congestion, Pain, Pruritus, Tinnitus
Clinical narrative: I had a stuffy nose. Rash at the injection site. Headache. Ear ringing. Ear pressure. Body aches. Extreme fatigue. Developed two small circular areas (2-4mm)  3 days post vaccination on my right forearm and left upper arm with a reddened circle with a white center, mild itching also noted. These areas disappeared when cleaned and antibacterial ointment applied overnight.
Age: 5.0
Sex: M
Vaccine: HIBV, PPV, VARCEL
Symptoms: Confusional state, Dysarthria, Excessive eye blinking, Fatigue, Pyrexia
Clinical narrative: Pt spiked a temperature of 103.2, 24 hours after vaccines were administered. Fever lasted 20 hours. He was fatigued and drowsy for 3 days following administration. Approximately 8 days after vaccines he started with a eye blink tic, repeating his words, and acting confused with slurred speech. It is now 2 months post vaccine administration and his eye blinking tic is constant at all waking hours, his word repeating is every few sentences, but speech slurring is clear again.
Age: 5.0
Sex: M
Vaccine: HIBV, PPV, VARCEL
Symptoms: Somnolence, Speech disorder
Clinical narrative: Pt spiked a temperature of 103.2, 24 hours after vaccines were administered. Fever lasted 20 hours. He was fatigued and drowsy for 3 days following administration. Approximately 8 days after vaccines he started with a eye blink tic, repeating his words, and acting confused with slurred speech. It is now 2 months post vaccine administration and his eye blinking tic is constant at all waking hours, his word repeating is every few sentences, but speech slurring is clear again.
Age: 12.0
Sex: F
Vaccine: HPV9
Symptoms: Expired product administered, Immunisation, No adverse event
Clinical narrative: GARDASIL vaccine administered with no problems. When I was documenting the vaccine, it was noted that it expired 7-30-2018. I was administering 8-2-2018. I was decided after checking with supervisor that because it was expired, another dose should be given. GARDASIL, lot M042853 was administered in her right deltoid. No reactions were noted at this time.
Age: 55.0
Sex: F
Vaccine: VARZOS
Symptoms: Arthralgia, Decreased appetite, Fatigue, Loss of personal independence in daily activities, Myalgia
Clinical narrative: Fever, every muscle ached, pain in every joint, extremely tired, nauseous (threw up once), no appetite, unable to function out of bed.
Age: 55.0
Sex: F
Vaccine: VARZOS
Symptoms: Nausea, Pyrexia, Vomiting
Clinical narrative: Fever, every muscle ached, pain in every joint, extremely tired, nauseous (threw up once), no appetite, unable to function out of bed.
Age: 63.0
Sex: F
Vaccine: VARZOS
Symptoms: Erythema, Injection site warmth, Swelling
Clinical narrative: Patient complained of redness, swelling. said injection site was warm, but, overall, getting better.
Age: 17.0
Sex: F
Vaccine: MENB, MNQ
Symptoms: Dizziness, Erythema, Fatigue, Headache, Immediate post-injection reaction
Clinical narrative: Immediate arm pain, redness, also HA, dizzy, fatigue 3-4 days.
Age: 17.0
Sex: F
Vaccine: MENB, MNQ
Symptoms: Pain in extremity
Clinical narrative: Immediate arm pain, redness, also HA, dizzy, fatigue 3-4 days.
Age: 15.0
Sex: F
Vaccine: HEPA
Symptoms: Inappropriate schedule of drug administration, No adverse event
Clinical narrative: Client presented to health department for HPV dose #2. Discussed immunization history/recommended vaccinations. Reviewed immunization record and noted Hep A incomplete. Looked incorrectly at the HPV line to see the recommended due date of 8/12/2018 and prepared and administered the Hep A dose too soon. Discussed mistake with parent/client. No reaction noted/reported. Discussed next due dates for each immunization in series and encouraged to call/return with any noted reaction.
Age: 17.0
Sex: M
Vaccine: HEPA, HPV9, MENB
Symptoms: Chills, Cyanosis, Erythema, Nausea, Pyrexia
Clinical narrative: Mother reported several hours after immunizations face became red, lips turned blue, had chills, nausea, fever 101.5. TYLENOL given. Mother reported improvement in symptoms 30 min after TYLENOL was given.
Age: 17.0
Sex: M
Vaccine: MENB
Symptoms: Syncope, Unresponsive to stimuli
Clinical narrative: On 8/6/2018 the I.M. injection of Meningitis B (BEXSERO) was given in right deltoid at 7:50 a.m. and within 3 seconds, patient closed his eyes and his head went back fainting. This lasted 5 seconds before he eventually responded and opened eyes.
Age: 20.0
Sex: U
Vaccine: HEPA, TYP
Symptoms: Dizziness
Clinical narrative: Pt. had feeling of dizziness. BP 88/60. 97 - 60. Given juice and water. Follow up vitals BP 92/60 - no loss of consciousness.
Age: 63.0
Sex: F
Vaccine: VARZOS
Symptoms: Arthralgia, C-reactive protein, Full blood count, Injection site pain, Joint swelling
Clinical narrative: It started the day I got the injection. There was a dull ache and pain at the site. I was told that was normal. It continued and at day 4, I started getting aches and pains in my neck, both knees, feet and hands. There was noticeable swelling in these joints. As the days progressed, the aches and pain radiated to my elbows. I finally made an appointment to see my doctor. I went in on July 25, 2018 and described what I was going through. The CNP did some blood work and told me to try TYLENOL Extra Strength and ASPERCREAM with Lidocaine. I tried both, but neither worked. The blood work came back, showed inflammation. I asked about the vaccine, since the time frame seemed to correlate to all my symptoms. The nurse called me back and spoke to my doctor as well as an internal medicine doctor on staff, and both agreed that it could be an adverse reaction to the vaccine. The internal medicine doctor said he had a patient with similar symptoms caused by the vaccine and the symptoms lasted about 6 weeks. I was advised NOT to get the 2nd part of the vaccine. I am now week 7 and there hasn't been any significant change. Last week, the swelling, aches and pains were so severe that I couldn't get out of bed, out of a chair or get dressed or do any activities of daily living without the assistance from my husband. The pain may subside a little for a little while and then come back again, but the ache and swelling is constant. I have also tried ice packs, soaking the extremities in cold water. It gives me temporary relief. I have been taking ibuprofen 400 mg in the morning and at night and that seems to help a little, but the swelling still remains in the joints. I have not experienced any fever, headache or the like. Prior to this vaccine, I had no problems with my joints. I have a follow up visit with my primary care doctor September 24th. If the symptoms don't get any better before that, I will have to try to get to see another doctor or go to the ER. I should mention that I thought the pharmacy assistant who gave me the injection gave it up too high on my arm. It was almost to the shoulder. He gave my husband the injection as well, in the same area of his arm, but my husband only had flu like symptoms for a few days. I would also like to mention that I received the original Shingles vaccine (ZOSTAVAX) on November 27, 2014 when I turned 60. I did not have any reaction to that vaccine. I also forgot to mention that there were 2 days where the injection site hurt so badly that I couldn't lift my arm at all.
Age: 63.0
Sex: F
Vaccine: VARZOS
Symptoms: Loss of personal independence in daily activities, Mobility decreased, Neck pain, Pain, Pain in extremity
Clinical narrative: It started the day I got the injection. There was a dull ache and pain at the site. I was told that was normal. It continued and at day 4, I started getting aches and pains in my neck, both knees, feet and hands. There was noticeable swelling in these joints. As the days progressed, the aches and pain radiated to my elbows. I finally made an appointment to see my doctor. I went in on July 25, 2018 and described what I was going through. The CNP did some blood work and told me to try TYLENOL Extra Strength and ASPERCREAM with Lidocaine. I tried both, but neither worked. The blood work came back, showed inflammation. I asked about the vaccine, since the time frame seemed to correlate to all my symptoms. The nurse called me back and spoke to my doctor as well as an internal medicine doctor on staff, and both agreed that it could be an adverse reaction to the vaccine. The internal medicine doctor said he had a patient with similar symptoms caused by the vaccine and the symptoms lasted about 6 weeks. I was advised NOT to get the 2nd part of the vaccine. I am now week 7 and there hasn't been any significant change. Last week, the swelling, aches and pains were so severe that I couldn't get out of bed, out of a chair or get dressed or do any activities of daily living without the assistance from my husband. The pain may subside a little for a little while and then come back again, but the ache and swelling is constant. I have also tried ice packs, soaking the extremities in cold water. It gives me temporary relief. I have been taking ibuprofen 400 mg in the morning and at night and that seems to help a little, but the swelling still remains in the joints. I have not experienced any fever, headache or the like. Prior to this vaccine, I had no problems with my joints. I have a follow up visit with my primary care doctor September 24th. If the symptoms don't get any better before that, I will have to try to get to see another doctor or go to the ER. I should mention that I thought the pharmacy assistant who gave me the injection gave it up too high on my arm. It was almost to the shoulder. He gave my husband the injection as well, in the same area of his arm, but my husband only had flu like symptoms for a few days. I would also like to mention that I received the original Shingles vaccine (ZOSTAVAX) on November 27, 2014 when I turned 60. I did not have any reaction to that vaccine. I also forgot to mention that there were 2 days where the injection site hurt so badly that I couldn't lift my arm at all.